U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 100 points on Tuesday.
The Dow traded up 0.40% to 33,653.27 while the NASDAQ rose 0.83% to 10,724.37. The S&P 500 also rose, gaining, 0.55% to 3,913.66.
Clinical Program Updates
Phase 2 Trial of Mecbotamab Vedotin (BA3011, NCT03425279) in Patients with:
AXL-positive NSCLC
Part 1 of the trial ongoing in patients who have previously experienced failure of
Gainers
Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares surged 78% to $2.2399 as the stock continued to see momentum despite the company last week announcing it is not aware of any developments that would explain the recent surge.